Nerve growth factor metabolic dysfunction in Alzheimer's disease and Down syndrome

Trends in Pharmacological Sciences

Volumn 35, Issue 7, 2014, Pages 338-348

  Iulita, M Florencia ^a   Cuello, A Claudio ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; basal forebrain cholinergic neurons; Down syndrome; matrix metalloprotease 9; nerve growth factor

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN; CHOLINE ACETYLTRANSFERASE; GELATINASE B; NERVE GROWTH FACTOR; STROMELYSIN;

AGING; ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN SIZE; CELL METABOLISM; CELL SURVIVAL; CHOLINERGIC NERVE CELL; COMPLEX FORMATION; DISEASE ASSOCIATION; DOWN SYNDROME; ENZYME ACTIVITY; FOREBRAIN; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; METABOLIC DISORDER; MILD COGNITIVE IMPAIRMENT; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER'S DISEASE; BASAL FOREBRAIN CHOLINERGIC NEURONS; DOWN SYNDROME; MATRIX METALLOPROTEASE 9; NERVE GROWTH FACTOR;

ALZHEIMER DISEASE; ANIMALS; DOWN SYNDROME; HUMANS; NERVE GROWTH FACTOR;

EID: 84903318473     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2014.04.010     Document Type: Review

References (169)

1. W. Thies et al. 2013 Alzheimer's disease facts and figures Alzheimers Dement. 9 2013 208 245
2. J.L. Cummings, and Z.S. Khachaturian Definitions and Diagnostic Criteria 2001 The Livery House
3. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766 (Pubitemid 32267077)
4. D.A. Bennett et al. Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function Arch. Neurol. 61 2004 378 384 (Pubitemid 38327357)
5. R.D. Terry Neuropathological changes in Alzheimer disease Prog. Brain Res. 101 1994 383 390 (Pubitemid 24084762)
6. G.G. Glenner, and C.W. Wong Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein Biochem. Biophys. Res. Commun. 122 1984 1131 1135 (Pubitemid 14027629)
7. C.L. Masters et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome Proc. Natl. Acad. Sci. U.S.A. 82 1985 4245 4249 (Pubitemid 15053619)
8. I. Grundke-Iqbal et al. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments J. Biol. Chem. 261 1986 6084 6089 (Pubitemid 17207447)
9. R.D. Terry et al. The Neuropathology of Alzheimer's Disease and the Structural Basis of its Cognitive Impairment 1999 Lippincott Williams & Wilkins
10. K.F. Bell, and A.C. Cuello Altered synaptic function in Alzheimer's disease Eur. J. Pharmacol. 545 2006 11 21 (Pubitemid 44219049)
11. E.J. Mufson et al. Cholinergic system during the progression of Alzheimer's disease: therapeutic implications Expert Rev. Neurother. 8 2008 1703 1718
12. P. Eikelenboom et al. Inflammation and Alzheimer's disease: relationships between pathogenic mechanisms and clinical expression Exp. Neurol. 154 1998 89 98 (Pubitemid 28553570)
13. M.A. Smith et al. Oxidative damage in Alzheimer's Nature 382 1996 120 121
14. R.C. Petersen Mild cognitive impairment as a diagnostic entity J. Intern. Med. 256 2004 183 194 (Pubitemid 39222988)
15. W.R. Markesbery et al. Neuropathologic substrate of mild cognitive impairment Arch. Neurol. 63 2006 38 46 (Pubitemid 43063860)
16. P.A. Boyle et al. Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline Neurology 67 2006 441 445 (Pubitemid 44214968)
17. R.J. Bateman et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease N. Engl. J. Med. 367 2012 795 804
18. C.R. Jack Jr et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers Lancet Neurol. 12 2013 207 216
19. P. Buchhave et al. Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia Arch. Gen. Psychiatry 69 2012 98 106
20. G. De Meyer et al. Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people Arch. Neurol. 67 2010 949 956
21. K.E. Pike et al. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease Brain 130 2007 2837 2844 (Pubitemid 350033975)
22. S.J. Vos et al. Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study Lancet Neurol. 12 2013 957 965
23. D.S. Knopman et al. Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease Neurology 78 2012 1576 1582
24. R.A. Sperling et al. Preclinical Alzheimer disease - the challenges ahead Nat. Rev. Neurol. 9 2013 54 58
25. K. Gardiner, and M. Davisson The sequence of human chromosome 21 and implications for research into Down syndrome Genome Biol. 1 2000 1 9 REVIEWS0002
26. I.T. Lott Neurological phenotypes for Down syndrome across the life span Prog. Brain Res. 197 2012 101 121
27. C.A. Lemere et al. Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation Neurobiol. Dis. 3 1996 16 32
28. C. Mori et al. Intraneuronal Aβ42 accumulation in Down syndrome brain Amyloid 9 2002 88 102 (Pubitemid 34787802)
29. J.K. Teller et al. Presence of soluble amyloid β-peptide precedes amyloid plaque formation in Down's syndrome Nat. Med. 2 1996 93 95
30. J. Busciglio et al. Altered metabolism of the amyloid β precursor protein is associated with mitochondrial dysfunction in Down's syndrome Neuron 33 2002 677 688 (Pubitemid 34219240)
31. J.B. Leverenz, and M.A. Raskind Early amyloid deposition in the medial temporal lobe of young Down syndrome patients: a regional quantitative analysis Exp. Neurol. 150 1998 296 304 (Pubitemid 28231961)
32. B.L. Handen et al. Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B Alzheimers Dement. 8 2012 496 501
33. K.E. Wisniewski et al. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome Ann. Neurol. 17 1985 278 282 (Pubitemid 15136603)
34. E.J. Mufson et al. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease J. Comp. Neurol. 427 2000 19 30
35. P.J. Whitehouse et al. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain Science 215 1982 1237 1239 (Pubitemid 12106486)
36. A.C. Cuello Effects of trophic factors on the CNS cholinergic phenotype Prog. Brain Res. 109 1996 347 358 (Pubitemid 27047103)
37. D.A. Drachman, and J. Leavitt Human memory and the cholinergic system. A relationship to aging? Arch. Neurol. 30 1974 113 121
38. R.T. Bartus et al. The cholinergic hypothesis of geriatric memory dysfunction Science 217 1982 408 414
39. D.M. Bowen et al. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies Brain 99 1976 459 496
40. P. Davies, and A.J. Maloney Selective loss of central cholinergic neurons in Alzheimer's disease Lancet 2 1976 1403 (Pubitemid 8004505)
41. E.K. Perry et al. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue J. Neurol. Sci. 34 1977 247 265 (Pubitemid 8188071)
42. S.T. DeKosky et al. Laminar organization of cholinergic circuits in human frontal cortex in Alzheimer's disease and aging Neurology 35 1985 1425 1431
43. M.M. Mesulam, and C. Geula Acetylcholinesterase-rich pyramidal neurons in the human neocortex and hippocampus: absence at birth, development during the life span, and dissolution in Alzheimer's disease Ann. Neurol. 24 1988 765 773 (Pubitemid 19019031)
44. C. Geula, and M.M. Mesulam Cortical cholinergic fibers in aging and Alzheimer's disease: a morphometric study Neuroscience 33 1989 469 481 (Pubitemid 20047882)
45. P. Etienne et al. Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease Neuroscience 19 1986 1279 1291 (Pubitemid 17217023)
46. C. Geula, and M.M. Mesulam Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease Cereb. Cortex 6 1996 165 177 (Pubitemid 26117394)
47. R.C. Pearson et al. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase Brain Res. 289 1983 375 379 (Pubitemid 14222546)
48. E.J. Mufson et al. Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain Exp. Neurol. 105 1989 221 232 (Pubitemid 19232573)
49. O.J. Vogels et al. Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease Neurobiol. Aging 11 1990 3 13 (Pubitemid 20097854)
50. M.M. Mesulam et al. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6) Neuroscience 10 1983 1185 1201 (Pubitemid 14178569)
51. M.M. Mesulam et al. Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry Neuroscience 12 1984 669 686 (Pubitemid 14092485)
52. M.M. Mesulam, and C. Geula Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase J. Comp. Neurol. 275 1988 216 240
53. M.M. Mesulam Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer's disease J. Comp. Neurol. 521 2013 4124 4144
54. J.A. Deutsch The cholinergic synapse and the site of memory Science 174 1971 788 794
55. R.T. Bartus, and H.R. Johnson Short-term memory in the rhesus monkey: disruption from the anti-cholinergic scopolamine Pharmacol. Biochem. Behav. 5 1976 39 46
56. M. Mesulam The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? Learn. Mem. 11 2004 43 49 (Pubitemid 38167057)
57. R.T. Bartus On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis Exp. Neurol. 163 2000 495 529 (Pubitemid 30399100)
58. E. Giacobini Invited review: cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications Neurochem. Int. 32 1998 413 419 (Pubitemid 28287193)
59. J.O. Rinne et al. Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease J. Neurol. Neurosurg. Psychiatry 74 2003 113 115 (Pubitemid 36069048)
60. K. Herholz et al. In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease Neuroimage 21 2004 136 143 (Pubitemid 38115004)
61. M. Iyo et al. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease Lancet 349 1997 1805 1809 (Pubitemid 27258658)
62. M. Grothe et al. Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease Neurobiol. Aging 34 2013 1210 1220
63. M. Grothe et al. Reduction of basal forebrain cholinergic system parallels cognitive impairment in patients at high risk of developing Alzheimer's disease Cereb. Cortex 20 2010 1685 1695
64. M.J. Grothe et al. Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects Alzheimers Dement. 9 2014 1 10 pii: S1552-5260(13)02846-X
65. S.T. DeKosky et al. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment Ann. Neurol. 51 2002 145 155 (Pubitemid 34111436)
66. T.P. Wong et al. Reorganization of cholinergic terminals in the cerebral cortex and hippocampus in transgenic mice carrying mutated presenilin-1 and amyloid precursor protein transgenes J. Neurosci. 19 1999 2706 2716 (Pubitemid 29162418)
67. K.F. Bell et al. Paradoxical upregulation of glutamatergic presynaptic boutons during mild cognitive impairment J. Neurosci. 27 2007 10810 10817 (Pubitemid 47535872)
68. C.M. Yates et al. Alzheimer-like cholinergic deficiency in Down syndrome Lancet 2 1980 979
69. M.F. Casanova et al. Abnormalities of the nucleus basalis in Down's syndrome Ann. Neurol. 18 1985 310 313 (Pubitemid 15023103)
70. D.M. Mann The pathological association between Down syndrome and Alzheimer disease Mech. Ageing Dev. 43 1988 99 136
71. M.J. Ball, and K. Nuttall Neurofibrillary tangles, granulovacuolar degeneration, and neuron loss in Down syndrome: quantitative comparison with Alzheimer dementia Ann. Neurol. 7 1980 462 465 (Pubitemid 10073126)
72. G.A. Jervis Early senile dementia in mongoloid idiocy Am. J. Psychiatry 105 1948 102 106
73. F. Lai, and R.S. Williams A prospective study of Alzheimer disease in Down syndrome Arch. Neurol. 46 1989 849 853 (Pubitemid 19199367)
74. V. Hamburger, and R. Levi-Montalcini Proliferation, differentiation and degeneration in the spinal ganglia of the chick embryo under normal and experimental conditions J. Exp. Zool. 111 1949 457 501
75. R. Levi-Montalcini, and V. Hamburger Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo J. Exp. Zool. 116 1951 321 361
76. S. Cohen et al. A nerve growth-stimulating factor isolated from sarcom as 37 and 180 Proc. Natl. Acad. Sci. U.S.A. 40 1954 1014 1018
77. M. Bibel, and Y.A. Barde Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system Genes Dev. 14 2000 2919 2937
78. M.V. Chao Neurotrophins and their receptors: a convergence point for many signalling pathways Nat. Rev. Neurosci. 4 2003 299 309 (Pubitemid 37271375)
79. A. Ullrich et al. Human β-nerve growth factor gene sequence highly homologous to that of mouse Nature 303 1983 821 825 (Pubitemid 13054499)
80. U. Francke et al. The human gene for the β subunit of nerve growth factor is located on the proximal short arm of chromosome 1 Science 222 1983 1248 1251 (Pubitemid 14202716)
81. R.H. Edwards et al. Differential RNA splicing predicts two distinct nerve growth factor precursors Nature 319 1986 784 787
82. J. Scott et al. Isolation and nucleotide sequence of a cDNA encoding the precursor of mouse nerve growth factor Nature 302 1983 538 540 (Pubitemid 13111140)
83. R.H. Angeletti et al. Subunit structure and amino acid composition of mouse submaxillary gland nerve growth factor Biochemistry 10 1971 463 469
84. R. Levi-Montalcini The nerve growth factor 35 years later Science 237 1987 1154 1162 (Pubitemid 17124912)
85. M. Seiler, and M.E. Schwab Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat Brain Res. 300 1984 33 39 (Pubitemid 14104091)
86. E.J. Mufson et al. Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: colocalization with cholinergic neurons J. Comp. Neurol. 285 1989 196 217 (Pubitemid 19186944)
87. E.P. Pioro, and A.C. Cuello Distribution of nerve growth factor receptor-like immunoreactivity in the adult rat central nervous system. Effect of colchicine and correlation with the cholinergic system - II. Brainstem, cerebellum and spinal cord Neuroscience 34 1990 89 110 (Pubitemid 20097898)
88. S. Korsching et al. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation EMBO J. 4 1985 1389 1393
89. D. Esposito et al. The cytoplasmic and transmembrane domains of the p75 and Trk A receptors regulate high affinity binding to nerve growth factor J. Biol. Chem. 276 2001 32687 32695
90. P. Kahle et al. p75 nerve growth factor receptor modulates p140trkA kinase activity, but not ligand internalization, in PC12 cells J. Neurosci. Res. 38 1994 599 606
91. D.R. Kaplan, and F.D. Miller Neurotrophin signal transduction in the nervous system Curr. Opin. Neurobiol. 10 2000 381 391 (Pubitemid 30389307)
92. A. Nykjaer et al. Sortilin is essential for proNGF-induced neuronal cell death Nature 427 2004 843 848 (Pubitemid 38297746)
93. M. Fahnestock et al. The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor J. Neurochem. 89 2004 581 592 (Pubitemid 38534144)
94. J.N. Kew et al. Nerve growth factor withdrawal induces the apoptotic death of developing septal cholinergic neurons in vitro: protection by cyclic AMP analogue and high potassium Neuroscience 70 1996 329 339 (Pubitemid 126755247)
95. Y. Li et al. Regulation of TrkA and ChAT expression in developing rat basal forebrain: evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons J. Neurosci. 15 1995 2888 2905
96. K.S. Chen et al. Disruption of a single allele of the nerve growth factor gene results in atrophy of basal forebrain cholinergic neurons and memory deficits J. Neurosci. 17 1997 7288 7296 (Pubitemid 27413260)
97. C. Crowley et al. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons Cell 76 1994 1001 1011 (Pubitemid 24106381)
98. R.J. Smeyne et al. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene Nature 368 1994 246 249 (Pubitemid 24108841)
99. M.V. Sofroniew et al. Survival of adult basal forebrain cholinergic neurons after loss of target neurons Science 247 1990 338 342
100. T. Debeir et al. A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat Proc. Natl. Acad. Sci. U.S.A. 96 1999 4067 4072 (Pubitemid 29169037)
101. B.C. Figueiredo et al. NGF prevents further atrophy of cholinergic cells of the nucleus basalis due to cortical infarction in adult post-hypothyroid rats but does not restore cell size compared to euthyroid [correction of euthroid] rats J. Chem. Neuroanat. 12 1996 15 27 (Pubitemid 27026062)
102. F. Hefti Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections J. Neurosci. 6 1986 2155 2162 (Pubitemid 16043658)
103. J.L. Venero et al. Expression of neurotrophin and trk receptor genes in adult rats with fimbria transections: effect of intraventricular nerve growth factor and brain-derived neurotrophic factor administration Neuroscience 59 1994 797 815 (Pubitemid 24149091)
104. L. Garofalo, and A.C. Cuello Pharmacological characterization of nerve growth factor and/or monosialoganglioside GM1 effects on cholinergic markers in the adult lesioned brain J. Pharmacol. Exp. Ther. 272 1995 527 545
105. M. Eriksdotter Jonhagen et al. Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease Dement. Geriatr. Cogn. Disord. 9 1998 246 257
106. M.H. Tuszynski et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease Nat. Med. 11 2005 551 555 (Pubitemid 40691288)
107. F. Hefti, and W.J. Weiner Nerve growth factor and Alzheimer's disease Ann. Neurol. 20 1986 275 281 (Pubitemid 16018509)
108. M. Fahnestock et al. Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex Brain Res. Mol. Brain Res. 42 1996 175 178 (Pubitemid 26345425)
109. M. Goedert et al. Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease Brain Res. 387 1986 85 92
110. N. Jette et al. NGF mRNA is not decreased in frontal cortex from Alzheimer's disease patients Brain Res. Mol. Brain Res. 25 1994 242 250 (Pubitemid 24266074)
111. M. Fahnestock et al. The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease Mol. Cell. Neurosci. 18 2001 210 220 (Pubitemid 32846529)
112. M.A. Bruno et al. Amyloid β-induced nerve growth factor dysmetabolism in Alzheimer disease J. Neuropathol. Exp. Neurol. 68 2009 857 869
113. C.E. Pedraza et al. Pro-NGF isolated from the human brain affected by Alzheimer's disease induces neuronal apoptosis mediated by p75NTR Am. J. Pathol. 166 2005 533 543 (Pubitemid 40189049)
114. D.R. Kaplan, and F.D. Miller Neurobiology: a move to sort life from death Nature 427 2004 798 799 (Pubitemid 38297730)
115. M.A. Bruno, and A.C. Cuello Activity-dependent release of precursor nerve growth factor, conversion to mature nerve growth factor, and its degradation by a protease cascade Proc. Natl. Acad. Sci. U.S.A. 103 2006 6735 6740
116. P.A. Bresnahan et al. Human fur gene encodes a yeast KEX2-like endoprotease that cleaves pro-β-NGF in vivo J. Cell Biol. 111 1990 2851 2859 (Pubitemid 120034026)
117. N.G. Seidah et al. Cellular processing of the nerve growth factor precursor by the mammalian pro-protein convertases Biochem. J. 314 1996 951 960 (Pubitemid 26097761)
118. A. Blochl, and H. Thoenen Characterization of nerve growth factor (NGF) release from hippocampal neurons: evidence for a constitutive and an unconventional sodium-dependent regulated pathway Eur. J. Neurosci. 7 1995 1220 1228
119. A. Blochl, and H. Thoenen Localization of cellular storage compartments and sites of constitutive and activity-dependent release of nerve growth factor (NGF) in primary cultures of hippocampal neurons Mol. Cell. Neurosci. 7 1996 173 190 (Pubitemid 26171702)
120. M. Yepes, and D.A. Lawrence Tissue-type plasminogen activator and neuroserpin: a well-balanced act in the nervous system? Trends Cardiovasc. Med. 14 2004 173 180 (Pubitemid 38942824)
121. E. Miranda, and D.A. Lomas Neuroserpin: a serpin to think about Cell. Mol. Life Sci. 63 2006 709 722
122. V.W. Yong et al. Metalloproteinases in biology and pathology of the nervous system Nat. Rev. Neurosci. 2 2001 502 511 (Pubitemid 33676585)
123. S. Fabbro, and N.W. Seeds Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain J. Neurochem. 109 2009 303 315
124. S. Allard et al. Impact of the NGF maturation and degradation pathway on the cortical cholinergic system phenotype J. Neurosci. 32 2012 2002 2012
125. C. Tiveron et al. ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice Cell Death Differ. 20 2013 1017 1030
126. E.J. Mufson et al. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease Exp. Neurol. 146 1997 91 103 (Pubitemid 27319723)
127. S.E. Counts et al. Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease Ann. Neurol. 56 2004 520 531 (Pubitemid 39319342)
128. S.D. Ginsberg et al. Downregulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease J. Neurochem. 97 2006 475 487
129. S. Peng et al. Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease J. Neuropathol. Exp. Neurol. 63 2004 641 649 (Pubitemid 38736427)
130. M.A. Bruno et al. Increased matrix metalloproteinase 9 activity in mild cognitive impairment J. Neuropathol. Exp. Neurol. 68 2009 1309 1318
131. R.M. Nitsch et al. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors Science 258 1992 304 307
132. S. Capsoni, and A. Cattaneo On the molecular basis linking nerve growth factor (NGF) to Alzheimer's disease Cell. Mol. Neurobiol. 26 2006 619 633
133. F. Ruberti et al. Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy J. Neurosci. 20 2000 2589 2601 (Pubitemid 30220346)
134. E.K. Perry et al. Convergent cholinergic activities in aging and Alzheimer's disease Neurobiol. Aging 13 1992 393 400
135. D.E. Smith et al. Age-associated neuronal atrophy occurs in the primate brain and is reversible by growth factor gene therapy Proc. Natl. Acad. Sci. U.S.A. 96 1999 10893 10898 (Pubitemid 29442240)
136. P. Turrini et al. Cholinergic nerve terminals establish classical synapses in the rat cerebral cortex: synaptic pattern and age-related atrophy Neuroscience 105 2001 277 285 (Pubitemid 32728112)
137. W. Fischer et al. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor Nature 329 1987 65 68 (Pubitemid 17125895)
138. M.A. Bruno et al. Long-lasting rescue of age-associated deficits in cognition and the CNS cholinergic phenotype by a partial agonist peptidomimetic ligand of TrkA J. Neurosci. 24 2004 8009 8018 (Pubitemid 39280820)
139. A. Martinez-Serrano et al. Ex vivo gene transfer of brain-derived neurotrophic factor to the intact rat forebrain: neurotrophic effects on cholinergic neurons Eur. J. Neurosci. 8 1996 727 735 (Pubitemid 26114617)
140. M.A. Bruno, and A.C. Cuello Cortical peroxynitration of nerve growth factor in aged and cognitively impaired rats Neurobiol. Aging 33 2012 1927 1937
141. M.F. Iulita et al. Nerve growth factor metabolic dysfunction in Down's syndrome brains Brain 137 2014 860 872
142. A. Salehi et al. Using mouse models to explore genotype-phenotype relationship in Down syndrome Ment. Retard. Dev. Disabil. Res. Rev. 13 2007 207 214 (Pubitemid 47613274)
143. J.D. Cooper et al. Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal of cholinergic neurodegenerative phenotypes following NGF infusion Proc. Natl. Acad. Sci. U.S.A. 98 2001 10439 10444 (Pubitemid 32803038)
144. A. Salehi et al. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration Neuron 51 2006 29 42 (Pubitemid 43963336)
145. J.R. Backstrom et al. Characterization of neutral proteinases from Alzheimer-affected and control brain specimens: identification of calcium-dependent metalloproteinases from the hippocampus J. Neurochem. 58 1992 983 992
146. C. Hock et al. Increased CSF levels of nerve growth factor in patients with Alzheimer's disease Neurology 54 2000 2009 2011 (Pubitemid 30327130)
147. I. Blasko et al. Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias Dement. Geriatr. Cogn. Disord. 21 2006 9 15 (Pubitemid 41797965)
148. F. Mashayekhi, and Z. Salehin Cerebrospinal fluid nerve growth factor levels in patients with Alzheimer's disease Ann. Saudi Med. 26 2006 278 282 (Pubitemid 44679987)
149. C.E. Hanzel et al. Analysis of matrix metallo-proteases and the plasminogen system in mild cognitive impairment and Alzheimer's disease cerebrospinal fluid J. Alzheimers Dis. 40 2014 667 678
150. H.M. Nielsen et al. Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies Neurology 69 2007 1569 1579 (Pubitemid 350287140)
151. S. Lorenzl et al. Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease Neurochem. Int. 43 2003 191 196 (Pubitemid 36422625)
152. S. Horstmann et al. Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease Int. Psychogeriatr. 22 2010 966 972
153. E. Stomrud et al. Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease Alzheimers Res. Ther. 2 2010 20
154. J.C. Adair et al. Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease Stroke 35 2004 e159 e162
155. Y. Yoshiyama et al. Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain Acta Neuropathol. 99 2000 91 95 (Pubitemid 30093413)
156. Y.S. Kim et al. A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation FASEB J. 21 2007 179 187
157. Y. Ogata et al. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9 J. Biol. Chem. 267 1992 3581 3584
158. J.C. Morris, and D.J. Selkoe Recommendations for the incorporation of biomarkers into Alzheimer clinical trials: an overview Neurobiol. Aging 32 Suppl. 1 2011 S1 S3
159. P.E. Gottschall et al. Increased production of gelatinase B (matrix metalloproteinase-9) and interleukin-6 by activated rat microglia in culture J. Neurosci. Res. 42 1995 335 342
160. P.E. Gottschall, and X. Yu Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes J. Neurochem. 64 1995 1513 1520
161. Z. Gu et al. S-Nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death Science 297 2002 1186 1190 (Pubitemid 36193354)
162. M.T. Ferretti et al. Transgenic mice as a model of pre-clinical Alzheimer's disease Curr. Alzheimer Res. 8 2011 4 23
163. M.T. Ferretti et al. Intracellular Aβ-oligomers and early inflammation in a model of Alzheimer's disease Neurobiol. Aging 33 2012 1329 1342
164. W.S. Griffin et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease Proc. Natl. Acad. Sci. U.S.A. 86 1989 7611 7615 (Pubitemid 19254506)
165. D.M. Wilcock Neuroinflammation in the aging Down syndrome brain; lessons from Alzheimer's disease Curr. Gerontol. Geriatr. Res. 2012 2012 170276
166. H. Akiyama et al. Inflammation and Alzheimer's disease Neurobiol. Aging 21 2000 383 421 (Pubitemid 30349107)
167. P.L. McGeer et al. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR Neurosci. Lett. 79 1987 195 200 (Pubitemid 17144469)
168. M.T. Ferretti, and A.C. Cuello Does a pro-inflammatory process precede Alzheimer's disease and mild cognitive impairment? Curr. Alzheimer Res. 8 2011 164 174
169. J. Hu et al. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases Nat. Rev. Drug Discov. 6 2007 480 498 (Pubitemid 47064570)